This study is designed to see how safe a drug called AAA617 is for prostate cancer patients over a long time. AAA617 is a type of medicine used in certain cancer studies. Although you won't receive any treatment in this study, doctors will keep an eye on your health every 6-8 months for up to 10 years. They are looking to see if there are any serious side effects from the drug. Participation requires you to have completed some requirements from a separate study you were in before joining this one.
- Visits every 6-8 months for up to 10 years.
- No new treatment will be given, only health monitoring.
- The study length depends on when you received your first dose of AAA617 in the earlier study.